Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Chronic Pain in Elbow or Wrist

**Study: Treating Chronic Elbow or Wrist Pain with TAME Using Nexsphere-F** This study checks a new treatment called **Transcatheter Arterial Micro-Embolization (TAME)** using a drug **Nexsphere-F** for people aged 19-80 suffering from long-term elbow or wrist pain. The goal is to see if this treatment helps when regular therapies like painkillers or physical therapy aren't enough. The study will monitor the safety and effectiveness of Nexsphere-F by checking pain levels and any side effects. **Key Points:** - **Duration & Visits**: Study lasts 6 months with check-ins at 1, 3, and 6 months. - **Eligibility**: Participants must have moderate to severe pain (VAS score of 4 or more) and have not improved with standard treatments. - **Risks**: Possible side effects from the treatment will be monitored, ensuring safety. Before joining, ensure you haven't had elbow or wrist surgery, no severe kidney issues, and no allergies to specific dyes used in the procedure. If you meet the criteria and are interested, you’ll need to agree to participate and be able to attend all follow-up appointments.